NextPlat Corp. (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions, reported third-quarter 2026 revenue of approximately $10.5 million, compared with $13.8 million in the prior-year period, according to NextPlat (NASDAQ: NXPL, NXPLW). The decline reflects lower pharmacy reimbursement rates and retail prescription volumes.
Despite the revenue decline, gross margin improved to approximately 35% from 19.9%, while net loss attributable to common stockholders narrowed 66% to approximately $700,000, or $0.28 per diluted share, from $2.2 million, or $0.84 per diluted share. Pharmacy contract revenue increased 300% to approximately $2.4 million, driven by growth in higher-margin 340B services. E-commerce revenue rose 3% to approximately $3.8 million.
The company ended the quarter with approximately $11.2 million in cash and $13.5 million in working capital, with no material unsecured debt. NextPlat continued expanding its healthcare operations through the acquisition of Scott’s Pharmacy near Pensacola, Florida, and the opening of a new Jacksonville location. The company also plans to launch a nationwide medication fulfillment website in the fourth quarter, providing consumers across all 50 states with online access to prescription and over-the-counter healthcare products.
Management expects contributions from its expanded pharmacy network and new contracted services to support future growth. For a full view of the press release, visit https://ibn.fm/8alUs. The latest news and updates relating to NXPL are available in the company’s newsroom at https://ibn.fm/NXPL.
The announcement was distributed by InvestorWire, a specialized communications platform focused on advanced wire-grade press release syndication. InvestorWire is one of 75+ brands within the Dynamic Brand Portfolio @ IBN, which delivers access to a vast network of wire solutions, including editorial syndication to 5,000+ outlets, enhanced press release enhancement, and social media distribution via IBN to millions of social media followers. InvestorWire also offers a full array of tailored corporate communications solutions. For more information, please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer.
